Samuel Benchimol

10.7k total citations · 4 hit papers
94 papers, 8.8k citations indexed

About

Samuel Benchimol is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Samuel Benchimol has authored 94 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Oncology, 60 papers in Molecular Biology and 22 papers in Genetics. Recurrent topics in Samuel Benchimol's work include Cancer-related Molecular Pathways (63 papers), Virus-based gene therapy research (19 papers) and RNA modifications and cancer (16 papers). Samuel Benchimol is often cited by papers focused on Cancer-related Molecular Pathways (63 papers), Virus-based gene therapy research (19 papers) and RNA modifications and cancer (16 papers). Samuel Benchimol collaborates with scholars based in Canada, United States and United Kingdom. Samuel Benchimol's co-authors include Homayoun Vaziri, David P. Lane, Yunping Lin, Weili Ma, Stephen W. Chung, Michael Mowat, Tak W. Mak, Loning Fu, Benjamin Rovinski and Rićhard P. Hill and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Samuel Benchimol

94 papers receiving 8.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span

1998 822 citations Homayoun Vaziri, Samuel Benchimol Current Biology profile →
Regulation of PTEN Transcription by p53

2001 753 citations Vuk Stambolic, David MacPherson et al. Molecular Cell profile →
p53: oncogene or anti-oncogene?

1990 705 citations Samuel Benchimol et al. profile →
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation

2003 584 citations Roger Leng, Yunping Lin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Samuel Benchimol Canada	46	5.7k	4.6k	1.4k	1.3k	1.2k	94	8.8k
Ada Sacchi Italy	55	5.8k 1.0×	3.7k 0.8×	1.5k 1.1×	550 0.4×	868 0.7×	162	8.4k
Stephen N. Jones United States	50	10.6k 1.9×	5.9k 1.3×	2.4k 1.8×	838 0.7×	1.1k 1.0×	114	13.2k
Mila E. McCurrach United States	20	7.3k 1.3×	3.6k 0.8×	1.3k 0.9×	2.1k 1.6×	614 0.5×	21	9.6k
Richard A. Ashmun United States	30	5.9k 1.0×	4.5k 1.0×	917 0.7×	493 0.4×	530 0.4×	53	8.4k
J.M. Trent United States	16	7.0k 1.2×	5.5k 1.2×	1.6k 1.2×	319 0.2×	1.1k 0.9×	25	9.6k
Asha S. Multani United States	40	5.0k 0.9×	3.3k 0.7×	1.9k 1.4×	1.4k 1.1×	428 0.4×	126	8.2k
Vjekoslav Dulić France	28	5.5k 1.0×	4.2k 0.9×	886 0.7×	1.1k 0.9×	563 0.5×	41	7.7k
Joanna Roberts United States	18	8.3k 1.5×	7.2k 1.6×	1.6k 1.1×	436 0.3×	630 0.5×	33	12.1k
Martha R. Stampfer United States	54	6.0k 1.1×	3.7k 0.8×	1.8k 1.3×	1.3k 1.0×	548 0.5×	132	9.4k
Takehiko Kamijo Japan	37	5.1k 0.9×	3.2k 0.7×	1.0k 0.8×	805 0.6×	455 0.4×	114	7.1k

Countries citing papers authored by Samuel Benchimol

Since Specialization

Citations

This map shows the geographic impact of Samuel Benchimol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel Benchimol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel Benchimol more than expected).

Fields of papers citing papers by Samuel Benchimol

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel Benchimol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel Benchimol. The network helps show where Samuel Benchimol may publish in the future.

Co-authorship network of co-authors of Samuel Benchimol

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel Benchimol. A scholar is included among the top collaborators of Samuel Benchimol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel Benchimol. Samuel Benchimol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Miller, David F., Farnoosh Abbas‐Aghababazadeh, Mark D. Minden, et al.. (2023). Heterogeneity in leukemia cells that escape drug-induced senescence-like state. Cell Death and Disease. 14(8). 503–503. 8 indexed citations

Ma, Weili, et al.. (2019). Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells. Cell Death and Disease. 10(1). 22–22. 19 indexed citations

Ma, Weili, Yunping Lin, Wanli Xuan, et al.. (2011). Inhibition of p53 expression by peptide-conjugated phosphorodiamidate morpholino oligomers sensitizes human cancer cells to chemotherapeutic drugs. Oncogene. 31(8). 1024–1033. 12 indexed citations

Bradley, Grace, et al.. (2007). The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma. British Journal of Cancer. 96(9). 1425–1432. 16 indexed citations

Benchimol, Samuel, et al.. (2006). Differential utilization of two ATP-generating pathways is regulated by p53. Cancer Cell. 10(1). 4–6. 36 indexed citations

Tsuchihara, Katsuya, Chris Bakal, Hitoshi Okada, et al.. (2005). Ckap2 Regulates Aneuploidy, Cell Cycling, and Cell Death in a p53-Dependent Manner. Cancer Research. 65(15). 6685–6691. 42 indexed citations

Lin, Yunping, Roger Leng, & Samuel Benchimol. (2005). Identification of p53-Regulated Genes by the Method of Differential Display. Humana Press eBooks. 317. 193–206. 1 indexed citations

Brown, Lauren M. & Samuel Benchimol. (2005). The Involvement of MAPK Signaling Pathways in Determining the Cellular Response to p53 Activation. Journal of Biological Chemistry. 281(7). 3832–3840. 80 indexed citations

Stambolic, Vuk, David MacPherson, Yunping Lin, et al.. (2001). Regulation of PTEN Transcription by p53. Molecular Cell. 8(2). 317–325. 753 indexed citations breakdown →

10.

Bradley, Grace, Jonathan Irish, Christina MacMillan, et al.. (2001). Abnormalities of the ARF-p53 pathway in oral squamous cell carcinoma. Oncogene. 20(5). 654–658. 36 indexed citations

11.

Abraham, Jacinth, David Spaner, & Samuel Benchimol. (1999). Phosphorylation of p53 protein in response to ionizing radiation occurs at multiple sites in both normal and DNA-PK deficient cells. Oncogene. 18(8). 1521–1527. 18 indexed citations

12.

Vaziri, Homayoun & Samuel Benchimol. (1998). Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Current Biology. 8(5). 279–282. 822 indexed citations breakdown →

13.

Bristow, Robert G., Qiyue Hu, Anne Jang, et al.. (1998). Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation. Oncogene. 16(14). 1789–1802. 39 indexed citations

14.

Fu, Loning, Mark D. Minden, & Samuel Benchimol. (1996). Translational regulation of human p53 gene expression.. The EMBO Journal. 15(16). 4392–4401. 124 indexed citations

15.

Bristow, Robert G., Samuel Benchimol, & Rićhard P. Hill. (1996). The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiotherapy and Oncology. 40(3). 197–223. 160 indexed citations

16.

Chang, Hong, et al.. (1995). p53 Mutations, c-myc and bcl-2 Rearrangements in Human Non-Hodgkin's Lymphoma Cell Lines. Leukemia & lymphoma. 19(1-2). 165–171. 31 indexed citations

17.

Lin, Yunping & Samuel Benchimol. (1995). Cytokines Inhibit p53-Mediated Apoptosis but Not p53-Mediated G₁ Arrest. Molecular and Cellular Biology. 15(11). 6045–6054. 67 indexed citations

18.

Slingerland, J., John R. Jenkins, & Samuel Benchimol. (1993). The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.. The EMBO Journal. 12(3). 1029–1037. 96 indexed citations

19.

Rovinski, Benjamin, Donald G. Munroe, Jim Peacock, et al.. (1987). Deletion of 5′-coding Sequences of the Cellular p53 Gene in Mouse Erythroleukemia: A Novel Mechanism of Oncogene Regulation. Molecular and Cellular Biology. 7(2). 847–853. 29 indexed citations

20.

Benchimol, Samuel, et al.. (1982). Bacteriophage lambda DNA packaging in vitro. The involvement of the lambda FI gene product, single-strand DNA, and a novel lambda-directed protein in the packaging reaction.. Journal of Biological Chemistry. 257(9). 5201–5210. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact